Kevin Lynch is a highly experienced and enthusiastic consultant Chief Medical Officer currently at QBiotics Group Limited and a co-founder of Populus Bio Sarl. They have managed drug development across national, regional, and global levels, building multi-disciplinary medical teams to launch transformational medicines in oncology, hematology, and immunology. Kevin has held influential roles at various organizations, including Chief Medical Officer at Antengene and Vice President at Celgene, and has contributed expertise as a board member and senior medical expert across multiple companies. Their extensive background encompasses both startup environments and larger, multinational operations. Kevin continues to engage in ongoing education at SVC and the University of Tasmania.
This person is not in the org chart
This person is not in any teams
This person is not in any offices